In This Issue
- Bringing Novel Therapies to More Patients with Hematologic Malignancies through the Blood Cancer Research Partnership (BCRP)
- Case Study: Adding Venetoclax to Azacitidine for Patients with AML
- Faculty Spotlight: Q&A with Austin Kim, MD
- New Medical Oncology Chair Benjamin Ebert Leads Myeloid Malignancies Research
- Sharing the Care of Stem Cell Transplant Patients
- Dana-Farber Cancer Institute's Network, Strategic Alliances, and Collaborators
Additional Resources
Hematologic Oncology Treatment Center
Clinical Trials for Hematologic Malignancies
Cellular Therapies Program
CAR T-Cell Therapy